Chargement en cours...
Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
BACKGROUND: Non-small-cell lung cancers (NSCLCs) harboring translocations in anaplastic lymphoma kinase (ALK) are highly sensitive to small-molecule ALK kinase inhibitors, such as crizotinib. CASE PRESENTATION: We describe a case of post-operative local recurrence of lung adenocarcinoma in an 81 yea...
Enregistré dans:
| Publié dans: | BMC Res Notes |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4415237/ https://ncbi.nlm.nih.gov/pubmed/25899913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1126-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|